APO Research
Talk to an analyst

APO RESEARCH · REPORT

Osimertinib Generics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Osimertinib Generics Industry Growth and Trends Forecast to 2032

27 December 202595 pages

Choose your research edition.

Industry ResearchOsimertinib Generics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Osimertinib Generics Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Osimertinib Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Osimertinib Generics Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Osimertinib Generics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Osimertinib Generics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Osimertinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Osimertinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Osimertinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Osimertinib Generics include Beacon, Drug International, General Pharmaceuticals, Pharmacil, Zydus and Wanbang Biopharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Osimertinib Generics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Osimertinib Generics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Osimertinib Generics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Osimertinib Generics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Osimertinib Generics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Osimertinib Generics Market by Company

Beacon

Drug International

General Pharmaceuticals

Pharmacil

Zydus

Wanbang Biopharmaceuticals

Osimertinib Generics Segment by Type

40mg per Tablet

80mg per Tablet

Osimertinib Generics Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Osimertinib Generics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Osimertinib Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Osimertinib Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Osimertinib Generics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Osimertinib Generics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Osimertinib Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 40mg per Tablet Table 2. Major Company of 80mg per Tablet Table 3. Global Osimertinib Generics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Osimertinib Generics Sales by Type (2021-2026) & (K Units) Table 5. Global Osimertinib Generics Sales Market Share in Volume by Type (2021-2026) Table 6. Global Osimertinib Generics Sales by Type (2021-2026) & (US$ Million) Table 7. Global Osimertinib Generics Sales Market Share in Value by Type (2021-2026) Table 8. Global Osimertinib Generics Price by Type (2021-2026) & (US$/Unit) Table 9. Global Osimertinib Generics Sales by Type (2027-2032) & (K Units) Table 10. Global Osimertinib Generics Sales Market Share in Volume by Type (2027-2032) Table 11. Global Osimertinib Generics Sales by Type (2027-2032) & (US$ Million) Table 12. Global Osimertinib Generics Sales Market Share in Value by Type (2027-2032) Table 13. Global Osimertinib Generics Price by Type (2027-2032) & (US$/Unit) Table 14. North America Osimertinib Generics Sales by Type (2021-2026) & (K Units) Table 15. North America Osimertinib Generics Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Osimertinib Generics Sales by Type (2021-2026) & (K Units) Table 17. Europe Osimertinib Generics Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Osimertinib Generics Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Osimertinib Generics Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Osimertinib Generics Sales by Type (2021-2026) & (K Units) Table 21. Latin America Osimertinib Generics Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Osimertinib Generics Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Osimertinib Generics Sales by Type (2021-2026) & (US$ Million) Table 24. Osimertinib Generics Industry Trends Table 25. Osimertinib Generics Industry Drivers Table 26. Osimertinib Generics Industry Opportunities and Challenges Table 27. Osimertinib Generics Industry Restraints Table 28. Global Osimertinib Generics Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Osimertinib Generics Revenue Market Share by Company (2021-2026) Table 30. Global Osimertinib Generics Sales by Company (2021-2026) & (K Units) Table 31. Global Osimertinib Generics Sales Share by Company (2021-2026) Table 32. Global Osimertinib Generics Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Osimertinib Generics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Osimertinib Generics Major Company Production Sites and Headquarters Table 35. Global Osimertinib Generics Company, Product Type & Application Table 36. Global Osimertinib Generics Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Osimertinib Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Osimertinib Generics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Osimertinib Generics Sales by Region (2021-2026) & (K Units) Table 41. Global Osimertinib Generics Sales Market Share in Volume by Region (2021-2026) Table 42. Global Osimertinib Generics Sales by Region (2021-2026) & (US$ Million) Table 43. Global Osimertinib Generics Sales Market Share in Value by Region (2021-2026) Table 44. Global Osimertinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Osimertinib Generics Sales by Region (2027-2032) & (K Units) Table 46. Global Osimertinib Generics Sales Market Share in Volume by Region (2027-2032) Table 47. Global Osimertinib Generics Sales by Region (2027-2032) & (US$ Million) Table 48. Global Osimertinib Generics Sales Market Share in Value by Region (2027-2032) Table 49. Global Osimertinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Osimertinib Generics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Osimertinib Generics Sales by Application (2021-2026) & (K Units) Table 52. Global Osimertinib Generics Sales Market Share in Volume by Application (2021-2026) Table 53. Global Osimertinib Generics Sales by Application (2021-2026) & (US$ Million) Table 54. Global Osimertinib Generics Sales Market Share in Value by Application (2021-2026) Table 55. Global Osimertinib Generics Price by Application (2021-2026) & (US$/Unit) Table 56. Global Osimertinib Generics Sales by Application (2027-2032) & (K Units) Table 57. Global Osimertinib Generics Sales Market Share in Volume by Application (2027-2032) Table 58. Global Osimertinib Generics Sales by Application (2027-2032) & (US$ Million) Table 59. Global Osimertinib Generics Sales Market Share in Value by Application (2027-2032) Table 60. Global Osimertinib Generics Price by Application (2027-2032) & (US$/Unit) Table 61. North America Osimertinib Generics Sales by Application (2021-2026) & (K Units) Table 62. North America Osimertinib Generics Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Osimertinib Generics Sales by Application (2021-2026) & (K Units) Table 64. Europe Osimertinib Generics Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Osimertinib Generics Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Osimertinib Generics Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Osimertinib Generics Sales by Application (2021-2026) & (K Units) Table 68. Latin America Osimertinib Generics Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Osimertinib Generics Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Osimertinib Generics Sales by Application (2021-2026) & (US$ Million) Table 71. Beacon Company Information Table 72. Beacon Business Overview Table 73. Beacon Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Beacon Osimertinib Generics Product Portfolio Table 75. Beacon Recent Development Table 76. Drug International Company Information Table 77. Drug International Business Overview Table 78. Drug International Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Drug International Osimertinib Generics Product Portfolio Table 80. Drug International Recent Development Table 81. General Pharmaceuticals Company Information Table 82. General Pharmaceuticals Business Overview Table 83. General Pharmaceuticals Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. General Pharmaceuticals Osimertinib Generics Product Portfolio Table 85. General Pharmaceuticals Recent Development Table 86. Pharmacil Company Information Table 87. Pharmacil Business Overview Table 88. Pharmacil Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Pharmacil Osimertinib Generics Product Portfolio Table 90. Pharmacil Recent Development Table 91. Zydus Company Information Table 92. Zydus Business Overview Table 93. Zydus Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Zydus Osimertinib Generics Product Portfolio Table 95. Zydus Recent Development Table 96. Wanbang Biopharmaceuticals Company Information Table 97. Wanbang Biopharmaceuticals Business Overview Table 98. Wanbang Biopharmaceuticals Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Wanbang Biopharmaceuticals Osimertinib Generics Product Portfolio Table 100. Wanbang Biopharmaceuticals Recent Development Table 101. North America Osimertinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Osimertinib Generics Sales by Country (2021-2026) & (K Units) Table 103. North America Osimertinib Generics Sales Market Share by Country (2021-2026) Table 104. North America Osimertinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Osimertinib Generics Sales Market Share Forecast by Country (2027-2032) Table 106. North America Osimertinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Osimertinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Osimertinib Generics Market Share by Country (2021-2026) Table 109. North America Osimertinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Osimertinib Generics Market Share Forecast by Country (2027-2032) Table 111. Europe Osimertinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Osimertinib Generics Sales by Country (2021-2026) & (K Units) Table 113. Europe Osimertinib Generics Sales Market Share by Country (2021-2026) Table 114. Europe Osimertinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Osimertinib Generics Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Osimertinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Osimertinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Osimertinib Generics Market Share by Country (2021-2026) Table 119. Europe Osimertinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Osimertinib Generics Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Osimertinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Osimertinib Generics Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Osimertinib Generics Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Osimertinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Osimertinib Generics Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Osimertinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Osimertinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Osimertinib Generics Market Share by Country (2021-2026) Table 129. Asia-Pacific Osimertinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Osimertinib Generics Market Share Forecast by Country (2027-2032) Table 131. Latin America Osimertinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Osimertinib Generics Sales by Country (2021-2026) & (K Units) Table 133. Latin America Osimertinib Generics Sales Market Share by Country (2021-2026) Table 134. Latin America Osimertinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Osimertinib Generics Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Osimertinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Osimertinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Osimertinib Generics Market Share by Country (2021-2026) Table 139. Latin America Osimertinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Osimertinib Generics Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Osimertinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Osimertinib Generics Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Osimertinib Generics Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Osimertinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Osimertinib Generics Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Osimertinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Osimertinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Osimertinib Generics Market Share by Country (2021-2026) Table 149. Middle East and Africa Osimertinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Osimertinib Generics Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Osimertinib Generics Distributors List Table 154. Osimertinib Generics Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Osimertinib Generics Image Figure 2. Global Osimertinib Generics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Osimertinib Generics Market Size (2021-2032) & (US$ Million) Figure 4. Global Osimertinib Generics Sales (2021-2032) & (K Units) Figure 5. 40mg per Tablet Image Figure 6. Global 40mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. 80mg per Tablet Image Figure 8. Global 80mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Osimertinib Generics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Osimertinib Generics Market Share by Type 2025 VS 2032 Figure 11. North America Osimertinib Generics Sales Market Share in Volume by Type in 2025 Figure 12. North America Osimertinib Generics Sales Market Share in Value by Type in 2025 Figure 13. Europe Osimertinib Generics Sales Market Share in Volume by Type in 2025 Figure 14. Europe Osimertinib Generics Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Osimertinib Generics Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Osimertinib Generics Sales Market Share in Value by Type in 2025 Figure 17. Latin America Osimertinib Generics Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Osimertinib Generics Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Osimertinib Generics Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Osimertinib Generics Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Osimertinib Generics Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Osimertinib Generics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Osimertinib Generics Market Share by Application 2025 VS 2032 Figure 31. North America Osimertinib Generics Sales Market Share in Volume by Application in 2025 Figure 32. North America Osimertinib Generics Sales Market Share in Value by Application in 2025 Figure 33. Europe Osimertinib Generics Sales Market Share in Volume by Application in 2025 Figure 34. Europe Osimertinib Generics Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Osimertinib Generics Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Osimertinib Generics Sales Market Share in Value by Application in 2025 Figure 37. Latin America Osimertinib Generics Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Osimertinib Generics Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Osimertinib Generics Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Osimertinib Generics Sales Market Share in Value by Application in 2025 Figure 41. North America Osimertinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Osimertinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Osimertinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Osimertinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Osimertinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Osimertinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Osimertinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Osimertinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Osimertinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Osimertinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Osimertinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Osimertinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Osimertinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Osimertinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Osimertinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Osimertinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Osimertinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Osimertinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Osimertinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Osimertinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Osimertinib Generics Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Osimertinib Generics Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg per Tablet
  • 80mg per Tablet
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Beacon
  • Drug International
  • General Pharmaceuticals
  • Pharmacil
  • Zydus
  • Wanbang Biopharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Osimertinib Generics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Osimertinib Generics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Osimertinib Generics Market by Type
  6. 1.3.1 40mg per Tablet
  7. 1.3.2 80mg per Tablet
  8. 1.4 Global Osimertinib Generics Market Size by Type
  9. 1.4.1 Global Osimertinib Generics Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Osimertinib Generics Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Osimertinib Generics Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Osimertinib Generics Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Osimertinib Generics Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Osimertinib Generics Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Osimertinib Generics Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Osimertinib Generics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Osimertinib Generics Industry Trends
  2. 2.2 Osimertinib Generics Industry Drivers
  3. 2.3 Osimertinib Generics Industry Opportunities and Challenges
  4. 2.4 Osimertinib Generics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Osimertinib Generics Revenue (2021-2026)
  2. 3.2 Global Top Players by Osimertinib Generics Sales (2021-2026)
  3. 3.3 Global Top Players by Osimertinib Generics Price (2021-2026)
  4. 3.4 Global Osimertinib Generics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Osimertinib Generics Major Company Production Sites & Headquarters
  6. 3.6 Global Osimertinib Generics Company, Product Type & Application
  7. 3.7 Global Osimertinib Generics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Osimertinib Generics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Osimertinib Generics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Osimertinib Generics Tier 1, Tier 2, and Tier 3
4 Osimertinib Generics Regional Status and Outlook
  1. 4.1 Global Osimertinib Generics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Osimertinib Generics Historic Market Size by Region
  3. 4.2.1 Global Osimertinib Generics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Osimertinib Generics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Osimertinib Generics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Osimertinib Generics Forecasted Market Size by Region
  7. 4.3.1 Global Osimertinib Generics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Osimertinib Generics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Osimertinib Generics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Osimertinib Generics by Application
  1. 5.1 Osimertinib Generics Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Osimertinib Generics Market Size by Application
  6. 5.2.1 Global Osimertinib Generics Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Osimertinib Generics Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Osimertinib Generics Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Osimertinib Generics Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Osimertinib Generics Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Osimertinib Generics Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Osimertinib Generics Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Osimertinib Generics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Beacon
  2. 6.1.1 Beacon Company Information
  3. 6.1.2 Beacon Business Overview
  4. 6.1.3 Beacon Osimertinib Generics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Beacon Osimertinib Generics Product Portfolio
  6. 6.1.5 Beacon Recent Developments
  7. 6.2 Drug International
  8. 6.2.1 Drug International Company Information
  9. 6.2.2 Drug International Business Overview
  10. 6.2.3 Drug International Osimertinib Generics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Drug International Osimertinib Generics Product Portfolio
  12. 6.2.5 Drug International Recent Developments
  13. 6.3 General Pharmaceuticals
  14. 6.3.1 General Pharmaceuticals Company Information
  15. 6.3.2 General Pharmaceuticals Business Overview
  16. 6.3.3 General Pharmaceuticals Osimertinib Generics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 General Pharmaceuticals Osimertinib Generics Product Portfolio
  18. 6.3.5 General Pharmaceuticals Recent Developments
  19. 6.4 Pharmacil
  20. 6.4.1 Pharmacil Company Information
  21. 6.4.2 Pharmacil Business Overview
  22. 6.4.3 Pharmacil Osimertinib Generics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pharmacil Osimertinib Generics Product Portfolio
  24. 6.4.5 Pharmacil Recent Developments
  25. 6.5 Zydus
  26. 6.5.1 Zydus Company Information
  27. 6.5.2 Zydus Business Overview
  28. 6.5.3 Zydus Osimertinib Generics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zydus Osimertinib Generics Product Portfolio
  30. 6.5.5 Zydus Recent Developments
  31. 6.6 Wanbang Biopharmaceuticals
  32. 6.6.1 Wanbang Biopharmaceuticals Company Information
  33. 6.6.2 Wanbang Biopharmaceuticals Business Overview
  34. 6.6.3 Wanbang Biopharmaceuticals Osimertinib Generics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Wanbang Biopharmaceuticals Osimertinib Generics Product Portfolio
  36. 6.6.5 Wanbang Biopharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Osimertinib Generics Sales by Country
  2. 7.1.1 North America Osimertinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Osimertinib Generics Sales by Country (2021-2026)
  4. 7.1.3 North America Osimertinib Generics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Osimertinib Generics Market Size by Country
  6. 7.2.1 North America Osimertinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Osimertinib Generics Market Size by Country (2021-2026)
  8. 7.2.3 North America Osimertinib Generics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Osimertinib Generics Sales by Country
  2. 8.1.1 Europe Osimertinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Osimertinib Generics Sales by Country (2021-2026)
  4. 8.1.3 Europe Osimertinib Generics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Osimertinib Generics Market Size by Country
  6. 8.2.1 Europe Osimertinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Osimertinib Generics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Osimertinib Generics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Osimertinib Generics Sales by Country
  2. 9.1.1 Asia-Pacific Osimertinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Osimertinib Generics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Osimertinib Generics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Osimertinib Generics Market Size by Country
  6. 9.2.1 Asia-Pacific Osimertinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Osimertinib Generics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Osimertinib Generics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Osimertinib Generics Sales by Country
  2. 10.1.1 South America Osimertinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Osimertinib Generics Sales by Country (2021-2026)
  4. 10.1.3 South America Osimertinib Generics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Osimertinib Generics Market Size by Country
  6. 10.2.1 South America Osimertinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Osimertinib Generics Market Size by Country (2021-2026)
  8. 10.2.3 South America Osimertinib Generics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Osimertinib Generics Sales by Country
  2. 11.1.1 Middle East and Africa Osimertinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Osimertinib Generics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Osimertinib Generics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Osimertinib Generics Market Size by Country
  6. 11.2.1 Middle East and Africa Osimertinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Osimertinib Generics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Osimertinib Generics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Osimertinib Generics Value Chain Analysis
  2. 12.1.1 Osimertinib Generics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Osimertinib Generics Production Mode & Process
  7. 12.2 Osimertinib Generics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Osimertinib Generics Distributors
  10. 12.2.3 Osimertinib Generics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst